from the activities of P-450 oxidases in these organs. BP also produced high levels of BPDE-I derived guanine adducts in foetal patas monkey tissues during at least the last 2/3 of gestation, with stage dependency and levels no less than 1/3 maternal levels. Binding to foetal patas and mouse tissues exhibited a tendency to peak before parturition, reflecting perhaps ontogenetic appearance of phase II conjugation enzymes, a kind of observation not predicted from study of phase I activation enzymes alone. Collectively, DNA adduct studies showed that foetal competence in metabolic activation is a critical determinant for risk. Foetal tissues (including possibly human foetuses) may be at more risk to certain types of chemical exposure than others.
IAI, has demonstrated that both maternal and foetal inducibility influence foetal tumourigenesis by a PAH, with maternal inducibility reducing and foetal inducibility increasing risk. Human relevance is being studied using the patas monkey foetomaternal system as a model. Aryl hydrocarbon hydroxylase (AHH) activity increased in patas maternal and foetal liver up to 5-fold after 50 mg benzpyrene kg-' and in placenta up to 100-fold. Monoclonal antibody inhibitory effects indicate that most of the induced activity was due to P450 IA1.
Continuing this theme, expression of cytochromes P450 in developing human liver was addressed by T especially A to T transversion in codon 61. Transplacental DMBA also increased the incidence and malignancy of liver tumours, with the H-ras oncogene codon 61 muta-ion in about 60%. The incidence of the oncogene mutation was similar in liver tumours arising after DMBA followed by postnatal treatment with the liver tumour promoter, phenobarbital (PB). Lung tumours instead showed mutated K-ras. Clones of mutated cells present shortly after exposure were identified by PCR amplification. By 2 weeks after birth, the skin, liver, and lung all had both H-ras and K-ras mutations at a rate of about 1 lo-. Similarly both H-ras and K-ras mutations occurred in DMBA-treated NIH3T3 cells, even though transformants eventually present mainly K-ras. Thus both mutations happen, as might be predicted from thermodynamic considerations, but which is recruited or expressed for transformation is specific to the cell type. Oestrogen from foetal ovaries is bound by a-foetoprotein to prevent masculinisation of the brain. DES does not bind to x-foetoprotein and so might alter these imprinting processes, including an eventual effect on levels of carcinogen-metabolising enzymes. This idea was tested in rats, using aflatoxin as a liver carcinogen after neonatal DES and PB in the drinking water as a liver tumour promoter. The incidences of liver neoplasms after aflatoxin-PB exposure were slightly higher in DES-pretreated vs control animals. An interesting unexpected finding was a 64% incidence of mammary lesions (mainly lobular hyperplasias and fibroadenomas) in the aflatoxin-PB treated females, but only 5% in those given DES also. Additional studies are required to sort out relative effects of the imprinting dose of DES on spontaneouslyarising tumours, on the metabolism of aflatoxin, and on promotive effects of PB. dioxin. An occupational grouping including machinists, welders, and other metal workers was associated with nonheritable retinoblastoma, similarly for pre-and postconception employment. Maternal grandparent's occupations were also examined: a strong association was found between the nonheritable retinoblastomas and grandparental occupation as farmers. Stored body burdens of pesticides in the mothers were suggested. Future plans include integration of molecular biology with epidemiology, for example, examination of specific changes in the retinoblastoma gene as related to paternal exposures. Comments A purpose of this Workshop was to clarify goals of the perinatal carcinogenesis field, and to this end some common themes emerged. (1) The time is past for narrow, self-contained dissection of phenomenology. Animal models should be relating to specific human cancer questions, especially ones that are not easily addressable by application of molecular biology to human material. Consideration of molecular/biochemical factors should ideally be done side-byside with human and rodent material, and since human material is often unobtainable, nonhuman primates may be particularly valuable in this regard. (2) Epidemiologists on the other hand should be working from thorough, detailed knowledge of animal model results, and more frequent dialogue between epidemiologists and experimentalists is needed. (3) The extent to which perinatal exposures influence incidence of adult-type cancers in humans remains an unplumbed but very important question. Interaction of oncogenic agents with the immature cells of the perinate would be expected to yield the typical undifferentiated tumours of childhood. On the other hand, in rodents, transplacentallyinitiated tumours are often morphologically similar to those caused in adults; tumours caused by low, environmental levels of carcinogen might have long latency; and results with DES or high fat exposure during pregnancy, and data on postnatal promoters and inhibitors, suggest persistent changes, some of them subtle, that can continue to be played upon by other influences throughout postnatal life. This question, of origin of typical aging-related human cancers from perinatal exposures, is a challenge for epidemiologists for obvious reasons; additional, carefully planned work with animals could help guide their efforts.
